Hepatitis C

Hepatitis C is a form of hepatitis, or 'inflammation of the liver,' caused by a virus known as the hepatitis C virus, or HCV. HCV infection is more common in Europe and the United States than HIV infection. It is estimated that between a quarter and a half million people in the United Kingdom are infected with HCV. Co-infection with HCV and HIV is a growing concern. Experts believe that 15 to 30% of HIV-positive people are also infected with HCV, but among injecting drug users and haemophiliacs, the rate can be as high as 90%.

HCV was first identified in 1989 and is similar to the viruses that cause yellow fever and Dengue fever. It is not related to hepatitis B virus, although it causes similar symptoms. HCV inhabits both the liver and the lymphatic system, and over time it may infect other organs too.

HCV infection can cause slowly progressive, long-term liver disease, ultimately leading to liver tissue damage, scarring (cirrhosis) and liver cancer.

Hepatitis information

For more information on hepatitis visit infohep.org.

Infohep is a project we're working on in partnership with the European Liver Patients Association (ELPA).

Visit infohep.org >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap